SCHEMBL829288

SCHEMBL829288

CCN(c1cc2c3c(c1)CCCCC3CCCC2)c1ncc(C(=O)O)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 11/20 0.48
RXRB P28702 6/20 0.48
RXRG P48443 6/20 0.48
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EGLN1 Q9GZT9 2/20 0.36
HCAR3 P49019 2/20 0.34
KDM4C Q9H3R0 2/20 0.34
KMO O15229 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM6B O15054 1/20 0.32
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL829812 0.97 RXRA (0.49) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL829380 0.88 RXRA (0.52) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL831240 0.85 KDM4E (0.43) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL829808 0.84 RXRA (0.53) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL830495 0.82 RXRB (0.47) RXRARXRBRXRGALDH1A1EGLN1
SCHEMBL830028 0.81 KDM4E (0.44) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL829946 0.80 RXRA (0.56) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL829859 0.79 RXRA (0.48) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL830332 0.72 KMO (0.49) KDM4EALDH1A1HSD17B10EGLN1KMO
SCHEMBL830231 0.72 AURKA (0.40) KDM4EALDH1A1EGLN1HCAR3KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143260-B2 Tricyclic amine compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-03-27 US disclosed
US-8143260-B2 Tricyclic amine compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-03-27 US disclosed
US-8143260-B2 Tricyclic amine compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-03-27 US disclosed
US-20110288299-A1 TRICYCLIC AMINE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-11-24 US disclosed
US-20110288299-A1 TRICYCLIC AMINE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-11-24 US disclosed
US-20110288299-A1 TRICYCLIC AMINE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288299-A1 TRICYCLIC AMINE COMPOUND RXRA, RXRB, NR2C2 RXRA 1/4885RXRB 2/4885RXRG 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.